No posts to display
Top News
MediPost Signs CDMO Agreement With Qstem for Dermal Papilla Cell Culture...
MediPost will establish a commercial-scale production system for Qstem’s hiPSC-based dermal papilla cell culture medium, expanding its CDMO business beyond cell therapies.
- Our Sponsors Ad -
